10-K: CareView Narrows Losses, Boosts Revenue Amid Going Concern Doubts

CareView Communications, Inc. reported reduced net and operating losses and increased revenue for fiscal year 2025, but continues to face substantial doubt about its ability to continue as a going concern.

Summary

• Net loss decreased to approximately $3.2 million in 2025 from $4.7 million in 2024.
• Operating loss significantly improved to approximately $55,000 in 2025 from $1.58 million in 2024.
• Total revenue increased by $765,000 to $9.02 million in 2025, up from $8.25 million in 2024, driven by recurring software revenue.
• Net cash provided by operating activities was $805,184 in 2025, a substantial improvement from net cash used of $305,029 in 2024.
• Cash balance increased to $1,546,883 at year-end 2025 from $759,266 at year-end 2024.
• Sales-based contracts aggregated sales price increased significantly to $2,533,000 in 2025 from $761,000 in 2024.
• The company's working capital deficit was $43,481,413 as of December 31, 2025.
• The maturity date for the $20 million PDL Credit Agreement was extended multiple times, most recently to June 30, 2026.
• A material weakness in internal control over financial reporting related to technical accounting matters was identified as of December 31, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed filing. While financial performance showed significant improvements in revenue growth and reduced losses, the persistent 'going concern' doubt and material weakness in internal controls present substantial risks, tempering overall positive sentiment.

Positives

• Operating loss significantly improved from $1.58 million in 2024 to $55,018 in 2025.
• Net loss decreased by approximately $1.5 million, from $4.7 million in 2024 to $3.2 million in 2025.
• Revenue increased by $765,000 (9.27%) to $9.02 million in 2025, driven by an increase in recurring software revenue.
• Operating cash flow turned positive, providing $805,184 in 2025 compared to using $305,029 in 2024.
• Cash and cash equivalents increased to $1,546,883 at year-end 2025 from $759,266 at year-end 2024.
• Aggregated sales price from sales-based contracts more than tripled, reaching $2,533,000 in 2025 from $761,000 in 2024.
• Operating expenses decreased by $757,000 (8%) in 2025, primarily due to reduced human resource costs and other product deployment costs.
• The HealthTrust Purchasing Agreement was extended through June 30, 2028.
• Received Innovative Technology designation in Q4 2022, signaling impact on patient care and business models.

Negatives

• Substantial doubt exists about the company's ability to continue as a going concern due to net losses and a significant working capital deficit of $43,481,413 as of December 31, 2025.
• Accumulated deficit increased to $215,786,551 as of December 31, 2025.
• A material weakness in internal control over financial reporting related to technical accounting matters was identified as of December 31, 2025.
• The company is highly dependent on a single customer, which accounted for 14.9% of revenue in 2025 and 16% of accounts receivable as of December 31, 2025.
• No cash retainers were paid to outside directors in 2025 or 2024 due to the company's financial position.
• Accrued interest payable increased to $22,896,139 in 2025 from $19,687,639 in 2024.

Risks

• **Going Concern**: The company's net losses and working capital deficit raise substantial doubt about its ability to continue as a going concern for the next 12 months without additional funding.
• **Cybersecurity Threats**: Heightened risks associated with cyber threats could adversely affect business operations, financial condition, and reputation, necessitating ongoing evaluation and updates to security measures.
• **Dependence on Key Individuals**: The company's attainment of profitable operations is dependent on key individuals.
• **Uncertainty of Product Development**: Risks associated with research, development, and successful testing of its products.
• **Dependence on Outside Capital**: Reliance on outside sources of capital to meet operating cash requirements, with no assurance that management's plans to raise capital will be successful.
• **Intellectual Property Protection**: Risks related to successful protection of intellectual property and susceptibility to infringement on the proprietary rights of others, with potential for expensive and time-consuming defense and enforcement.
• **Customer Concentration**: Significant reliance on one customer, which accounted for 14.9% of revenue in 2025 and 16% of accounts receivable as of December 31, 2025, posing a risk if this relationship changes.
• **Competition**: Competition in clinical video monitoring and fall prevention from companies like Cisco Systems, Avasure, Caregility, Royal Philips Electronics, Cerner Corporation, Stanley, Posey, Stryker, and Hill-Rom.
• **Regulatory Changes**: Inability to predict what competitive impact any regulatory development and advances in technology will have on future business and results of operations.
• **Internal Control Weakness**: A material weakness in internal control over financial reporting related to technical accounting matters was identified as of December 31, 2025, which could affect the ability to record, process, summarize, and report financial information accurately.

Future Outlook

Management plans to continue funding operations by increasing sales volumes, raising additional capital through sales of debt or equity securities or loans, controlling capital expenditures, managing new inventory orders, modifying debt, increasing sales outreach, streamlining and controlling general and administrative costs, and exploring new product/service offerings and business partnerships. The company is also assessing the impact of several recently issued accounting pronouncements on future financial statements.

Management Comments

• "Management has evaluated the significance of the conditions described above in relation to the Company’s ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the consolidated financial statements were issued."
• "While management will look to continue funding operations by increased sales volumes and raising additional capital from sources such as sales of its debt or equity securities or loans to meet operating cash requirements, there is no assurance that management’s plans will be successful."
• "Management believes that the condensed consolidated financial statements included in this report present, in all material respects, our financial condition, results of operations, and cash flows for the periods presented, notwithstanding the material weakness in internal control over financial reporting."
• "Management has determined that the Company did not maintain effective internal control over financial reporting as of the year ended December 31, 2025, due to the existence of the material weakness in technical accounting."

Industry Context

StockSavvy.ai notes that CareView Communications operates in the highly competitive and evolving healthcare technology sector, focusing on patient safety and long-term care. The increasing demand for remote patient monitoring and virtual nursing, driven by care demands and staffing shortages, aligns with CareView's product offerings like SitterView and TeleMedView. The company's strategic partnerships with Group Purchasing Organizations (HealthTrust, Premier, Vizient) and government contractors (Decisive Point, Shore Systems) are crucial for market penetration in a fragmented healthcare landscape. The emphasis on cybersecurity compliance reflects broader industry trends and regulatory pressures following recent SEC requirements.

Comparison to Industry Standards

• CareView's reported patient fall reduction of 80% and sitter cost reduction of over 65% with its Patient Safety System are strong performance indicators compared to traditional patient observation methods.
• Competitors like Cisco Systems, Avasure, Caregility, Royal Philips Electronics, and Cerner Corporation offer similar clinical video monitoring tools, but CareView claims a superior solution with better ROI and fall reduction, leveraging its patented Virtual Bed Rails and Virtual Chair Rails technology.
• Alternative fall prevention mechanisms from companies like Stanley, Posey, Stryker, and Hill-Rom (physical sensors, beds with fall alarms) represent a different approach, suggesting CareView competes in a segment valuing video-based predictive technology.
• The expansion into the long-term care market with CareView Connect, targeting approximately 2,000,000 skilled nursing beds and 3,000,000 assisted living beds, positions the company against a broader set of elder care technology providers, though specific competitors in this niche are not detailed in the filing.

Management Changes

Corporate Governance

Related Party Transactions

• Directors, officers, principal shareholders, and affiliates participated in certain financing activities in February and July 2018, May 2019, February 2020, and April, November, and December 2022.
• A debt-to-equity conversion was completed by directors, officers, principal shareholders, and affiliates between March and May 2023.
• Notes payable to related parties totaled $700,000 as of December 31, 2025.
• Accrued interest due related parties totaled $662,528 as of December 31, 2025.

Stakeholder Impact

• **Shareholders**: Potential for dilution if capital raise involves equity. Continued risk due to "going concern" doubt and material weakness in internal controls. Positive financial trends (reduced losses, increased revenue) could be beneficial if sustained.
• **Employees**: Remediation plan for internal controls includes identifying and employing additional highly qualified accounting personnel, potentially creating new job opportunities.
• **Customers (Hospitals/Healthcare Facilities)**: Continued provision of patient safety and quality of life systems, with 24x7x365 service and support. New sales-based model offers flexibility for facilities to capitalize on investment.
• **Creditors (e.g., PDL BioPharma, Inc.)**: Repeated extensions of the credit agreement maturity date indicate ongoing negotiations and potential for restructuring. Accrued interest payable continues to grow, posing a risk to timely repayment.

Next Steps

• Continue efforts to increase sales volumes and generate positive cash flows from operations.
• Seek additional funding through sales of debt or equity securities or loans.
• Implement remediation plan to address the material weakness in internal control over financial reporting, including hiring qualified accounting personnel, enhancing documentation, providing training, and automating controls.
• Actively evaluate and update cybersecurity measures to adapt to evolving threats and ensure ongoing compliance.
• Continue to work with HealthTrust and Premier members to expand contracts.
• Assess adoption timing and effects of new FASB accounting standards (ASU 2024-03, ASU 2024-04, ASU 2025-05, ASU 2025-06).
• Steven G. Johnson and Jason T. Thompson will continue to serve as Principal Executive Officer and Principal Financial Officer/Chief Accounting Officer, respectively, while the company seeks qualified candidates for CFO/Treasurer/Secretary roles.

Key Dates

Recommendation

While CareView Communications, Inc. demonstrated significant improvements in revenue growth and a substantial reduction in operating and net losses for fiscal year 2025, the persistent 'going concern' qualification and a material weakness in internal controls over financial reporting present considerable uncertainties. The company's reliance on a single major customer and the repeated extensions of its credit agreement maturity date also add to the risk profile. The positive operational momentum suggests potential for future stability, but the fundamental financial health issues warrant a cautious 'hold' stance until there is clear evidence of resolving the going concern and internal control deficiencies.

Keywords

Patient Safety System, Remote Patient Monitoring, Healthcare Technology, Virtual Nursing, Long-term Care, Cybersecurity, SEC Filing, Financial Performance, Going Concern, CRVW, Medical Devices, Patient Falls Prevention, Telehealth, Corporate Governance